Clinical trial
Changes of Left Ventricular Mass and Cardiac Function in Patients With Active Acromegaly During Treatment With the Growth Hormone Receptor Antagonist Pegvisomant: an Open-labelled, Prospective Study
NCT00552851 is registered in ClinicalTrials.gov with University of Wuerzburg as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Changes of Left Ventricular Mass and Cardiac Function in Patients With Active Acromegaly During Treatment With the Growth Hormone Receptor Antagonist Pegvisomant: an Open-labelled, Prospective Study
- Lead sponsor
- University of Wuerzburg
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- June 30, 2006
- Completion date
- December 31, 2010
- Enrollment
- 4 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.